- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05956184
Intrauterine Device Insertion and Felt Pain
Intrauterine Device Insertion and Felt Pain: Which Method is Better?
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The intrauterine device (IUD) is one of the commonly used methods of contraception due to its effectiveness in providing reliable contraception, its ease of application, non-obstruction of sexual life, affordability, minimal absolute contraindications, and reversibility. Despite this increasing preference, concerns regarding the use of both levonorgestrel-releasing and copper IUDs due to the potential pain and fear of pain during insertion, which has hindered the adoption of this method.
Although the conventional method is used for intrauterine device insertion, the authors defined the direct method, also known as the torpedo technique, in 2006. IUD practitioners have started to prefer this direct method because it is simpler, faster and has fewer insertion steps than the conventional technique. However, IUD practitioners should apply the most painless and tolerable method to women who choose an IUD for contraception. Therefore, in order to understand which method is less painful, patients will be divided into 2 groups as those who have IUD inserted with the conventional method and those who have IUD inserted with the direct method. At the end of the procedure, participants in both groups will be asked to rate the most severe pain they experienced during the procedure according to the Visual Analogue Scale (VAS) (from 0 to 10).
In the conventional method: the anterior lip of the cervix was grasped and pulled with Pozzi forceps, and after entering the uterine cavity with a hysterometry the IUD was inserted.
In the direct method: the anterior lip of the cervix was grasped and pulled with Pozzi forceps, and without using hysterometry the IUD was directly inserted.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Çankaya
-
Ankara, Çankaya, Turkey, 06800
- Ankara City Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Volunteer to participate in the study
- Preferring an intrauterine device for the contraceptive method
Exclusion Criteria:
- Patients with uterine leiomyoma
- Patients with endometriosis
- Patients with chronic pelvic pain
- Patients with familial mediterranean fever
- Patients who experienced complications during the procedure
- Patients who developed vasovagal reactions
- Patients who had previously used an IUD for any reason
- Patients with uterine anomalies
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Convention Method Group
Women who have an IUD inserted by conventional method will be asked to rate the most severe pain they experience during the procedure according to the Visual Analogue Scale (VAS) (from 0 to 10).
|
All womens will be placed in a gynecological position and underwent a bimanual examination to better determine whether the uterus was in the anteverted or retroverted position.
Subsequently, a speculum will be inserted, and the cervix will be disinfected with betadine.
In the conventional method: the anterior lip of the cervix is grasped and pulled with Pozzi forceps, and after entering the uterine cavity with a hysterometry the IUD is inserted.
In the direct method: the anterior lip of the cervix is grasped and pulled with Pozzi forceps, and without using hysterometry the IUD is directly inserted.
The strings will be cut approximately 2-3 cm after the cervix, and the Pozzi forceps and speculum will be removed.
The accuracy of the IUD placement will be confirmed using pelvic ultrasound.
The process will take about five minutes.
|
Active Comparator: Direct Method Group
Women who have an IUD inserted by direct method will be asked to rate the most severe pain they experience during the procedure according to the Visual Analogue Scale (VAS) (from 0 to 10).
|
All womens will be placed in a gynecological position and underwent a bimanual examination to better determine whether the uterus was in the anteverted or retroverted position.
Subsequently, a speculum will be inserted, and the cervix will be disinfected with betadine.
In the conventional method: the anterior lip of the cervix is grasped and pulled with Pozzi forceps, and after entering the uterine cavity with a hysterometry the IUD is inserted.
In the direct method: the anterior lip of the cervix is grasped and pulled with Pozzi forceps, and without using hysterometry the IUD is directly inserted.
The strings will be cut approximately 2-3 cm after the cervix, and the Pozzi forceps and speculum will be removed.
The accuracy of the IUD placement will be confirmed using pelvic ultrasound.
The process will take about five minutes.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Visual Analogue Scale (VAS)
Time Frame: Thirty minutes
|
This is a numeric pain score evaluated as "painless" (score=0) and "worst pain" (score=10).
Score <3 mild pain, 3-6 mild-moderate pain, and >6 moderate-to-severe pain.
|
Thirty minutes
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Mohammad I Halilzade, M.D., Ankara City Hospital Bilkent
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- ACH-KHD-MIH-01
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Intrauterine Device Migration
-
Cairo UniversityCompletedIntrauterine Device MigrationEgypt
-
Assiut UniversityCompletedIntrauterine Device MigrationEgypt
-
Fondation Ophtalmologique Adolphe de RothschildCompletedIntrauterine Device Migration | Menstrual CupFrance
-
Assiut UniversityCompletedIntrauterine DeviceEgypt
-
Cairo UniversityCompleted
-
Kanuni Sultan Suleyman Training and Research HospitalCompletedIntrauterine DeviceTurkey
-
Assiut UniversityCompleted
-
Cairo UniversityCompletedIntrauterine DeviceEgypt
-
noha mohamed elzaydyUnknown
-
University of KentuckyDuramed ResearchWithdrawnIntrauterine Device Placement
Clinical Trials on Intrauterine Device Insertion
-
BioceptiveUnknown
-
Assiut UniversityCompletedIntrauterine Device MigrationEgypt
-
University of British ColumbiaTerminatedInduced Abortion
-
University of British ColumbiaTerminated
-
Rutgers, The State University of New JerseyCompleted
-
Bnai Zion Medical CenterNot yet recruiting
-
Quanta MedicalCousin BiotechRecruitingDisk Herniated LumbarFrance
-
Yale UniversityPatient-Centered Outcomes Research Institute; University of California, Davis; Food and Drug Administration (FDA) and other collaboratorsCompletedContraception | Sterility, Female | Contraceptive Device; ComplicationsUnited States
-
Woman's Health University Hospital, EgyptCompleted
-
Université de SherbrookeCompletedDifficult IntubationCanada